Direkt zum Seiteninhalt, zur Hauptnavigation, zur Unternavigation, zur Fußzeile.

Industry Partners

Since its founding, immatics has fueled its growing business by partnering with academic institutions, hospitals, consulting companies and other businesses.

At present, the growing pipeline of novel tumor-associated antigens and immunotherapy products identified and developed by immatics offers numerous opportunities for co-development of our product candidates by pharmaceutical and biotech companies.

Biopharmaceutical companies with a focus on oncology and strong interest in the field of clinical development of active immunotherapy are welcome to contact us to find out more about co-development partnership.

Partnering

Companies and institutions seeking to find out more about partnering opportunities with immatics can directly contact us through: